![1]() - News- FDA tightens requirements for COVID-19 antibody tests- May 4, 2020- The U.S. Food and Drug Administration is tightening requirements for companies that develop COVID-19 antibody tests in an effort to combat fraud and better regulate the frenzy of tests coming to market.[[{"fid":"174399","view_mode":"medstat_image_flush_right","fields":{"... 
![1]() - News- Adding mechanical to pharma prophylaxis does not cut DVT incidence- May 4, 2020- Does adding mechanical prophylaxis to pharmacological prophylaxis lower the incidence of deep-vein thrombosis (DVT)? 
![1]() - News- Hydroxychloroquine-triggered QTc-interval prolongations mount in COVID-19 patients- May 4, 2020- Two single-center reports further documented the incidence of QTc-interval prolongations in COVID-19 patients treated with hydroxychloroquine. 
![1]() - News- FDA authorizes emergency use of remdesivir for COVID-19- May 2, 2020- The designation means remdesivir can be distributed in the United States and administered intravenously by healthcare providers, as appropriate, to treat severe disease. 
- News- CMS hikes telephone visit payments during pandemic- May 1, 2020- Physician groups praised the move to increase payments for telephone visits. 
![1]() - News- Primary care physicians reshuffle their work, lives in a pandemic- May 1, 2020- “Our knowledge of this disease is five steps behind, and changing at lightning speed,” said Dr. MaryAnn Dakkak. 
- News- Out-of-hospital cardiac arrests soar during COVID-19 in Italy- May 1, 2020- Four provinces in northern Italy report increases of various magnitudes, ranging from 18% to a stunning 187%. 
![1]() - News- Continuity rules- May 1, 2020- Hospital medicine outcomes are often hampered by suboptimal continuity of care. 
- News- Excess cancer deaths predicted as care is disrupted by COVID-19- May 1, 2020- Researchers are predicting that, 1 year from now, there will be 33,890 excess deaths among cancer patients in the United States over the age of 40. 
![1]() - News- New tetracycline antibiotic effective in acute bacterial skin and skin-structure infections- May 1, 2020- Is omadacycline, a new tetracycline-class antibiotic, as effective as linezolid in the treatment of acute bacterial skin and skin-structure infections? 






